Top section
Top section
Placement 3.7 times subscribed, weeks after regulator halted unauthorised marketing of a purported public offer
Markus Meier and Thore Zimmermann promoted
IPO pipeline strong, but timetables slipping as markets await clarity on tax, growth and defence funding
More articles
More articles
More articles
-
Animal healthcare company Huvepharma has opened the books on its €463m IPO on the Amsterdam Stock Exchange. -
Morgan Stanley managing director Tobias Åkermark is leaving the US firm to become head of Nordic banking and country CEO for Sweden at Barclays.
-
Chaoju Eye Care Holdings is gauging investor appetite for a HK$1.81bn ($233m) listing on the Hong Kong Stock Exchange, becoming the latest healthcare related company to seek an IPO.
-
Chinese technology companies are flocking back to the US for IPOs after months of poor market conditions and the regulatory crackdown on the sector brought deal flow to a near halt. There is more on the way too, as issuers look to wrap up deals before the summer slowdown. Jonathan Breen reports.
-
Biopharmaceutical company HutchMed (China) pocketed HK$4.17bn ($537.1m) this week from its Hong Kong IPO.
-
Round Hill Music Royalty Fund, the London-listed investment trust focused on song royalty streams, said on Thursday it intends to launch a share sale to finance its $120m forward pipeline of acquisitions.
Sub-sections
shared comment list
